Navigation Links
Study Links MS to Brain Chemical Deficiency
Date:2/15/2011

TUESDAY, Feb. 15 (HealthDay News) -- Multiple sclerosis is associated with reduced levels of an important neurotransmitter, noradrenaline -- a shortage caused by damage to an area of the brain called the locus coeruleus (LC), researchers have found.

Neurons in this part of the brain are a major source of noradrenaline, which plays an important role as an immunosuppressant in the brain, preventing inflammation and stress to neurons.

"There's a lot of evidence of damage to the LC in Alzheimer's and Parkinson's disease, but this is the first time that it has been demonstrated that there is stress involved to the neurons of the LC of MS patients, and that there is a reduction in brain noradrenaline levels," the study's first author, Paul Polak, a research specialist at the University of Illinois at Chicago, said in a university news release.

He and his colleagues found LC damage and reduced levels of noradrenaline in mice with MS and detected similar problems in the brains of people with the disease. The results suggest that LC damage and an accompanying reduction in noradrenaline levels may be common to many neurological diseases, they said.

The study was published online Feb. 4 in Brain.

"There are a number of FDA-approved drugs that have been shown to raise levels of noradrenaline in the brain, and we believe that this type of therapeutic intervention could benefit patients with MS and other neurodegenerative diseases, and should be investigated," Polak said.

More information

The American Academy of Family Physicians has more about multiple sclerosis.

-- Robert Preidt

SOURCE: University of Illinois at Chicago, news release, Feb. 11, 2011


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1

Related medicine news :

1. Kids Learn to Work Together Early, Study Finds
2. Study compares balanced propofol sedation with conventional sedation for therapeutic GI endoscopic procedures
3. Boston Medical Center critical care chief receives grant for lung injury study
4. Obesity Alone Raises Risk of Fatal Heart Attack, Study Finds
5. New study finds no cognitive impairment among ecstasy users
6. Obesity, Bum Knees Robbing Seniors of Good Years: Study
7. Playing Hard to Get May Get the Girl, Study Finds
8. Study Suggests Hearing Loss-Dementia Link
9. Energy Drinks May Hurt Kids: Study
10. Grant to study how to stop fumbled handoffs which can lead to medical errors
11. NIH study finds 2 pesticides associated with Parkinsons disease
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Study Links MS to Brain Chemical Deficiency
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... ... agency serving communities in the greater Dallas, Miami, and Raleigh regions, is organizing ... fighting to overcome a rare and deadly chromosome abnormality. , After struggling since ...
(Date:10/13/2017)... Milwaukee, WI (PRWEB) , ... October 13, 2017 , ... ... movement in medicine known as “patient engagement.” The patient is doing more than filling ... research partners. , “There is an increasing emphasis in health care and research ...
(Date:10/13/2017)... ... ... The American Board of Family Medicine's (ABFM) Board of Directors has selected ... Dr. James C. Puffer upon his retirement. Dr. Newton will serve in the position ... the end of 2018. Upon assuming the role of President and CEO on January ...
(Date:10/13/2017)... ... October 13, 2017 , ... PurhealthRX , a ... utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD oil will revolutionize the ... a CBD form that can be easily incorporated into liquid products, while reducing costs ...
(Date:10/13/2017)... ... ... Lori R. Somekh, founder of the Law Office of Somekh & ... and special needs planning attorneys. “Membership in ElderCounsel helps our office remain up to ... with elder law attorneys nationwide,” said Somekh. , ElderCounsel was founded ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... 28, 2017 Hill-Rom Holdings, Inc. (NYSE: HRC), ... call and webcast on Friday, November 3, 2017, beginning ... ending at approximately 8:30 a.m. (CDT) / 9:30 a.m. ... 2017 financial performance and guidance for 2018, Hill-Rom executives ... enhance operational performance, and long-range financial outlook through 2020. ...
(Date:9/27/2017)... NEW YORK , Sept. 27, 2017  DarioHealth Corp. ... big data solutions, today announced that its MyDario product is expected to ... TV listings for when The Dr. Oz Show airs in your area: ... The nine-time Emmy award-winning, ... ...
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, Inc. ... response letter from the U.S. Food and Drug Administration ... of sirukumab for the treatment of moderately to severely ... additional clinical data are needed to further evaluate the ... severely active RA. ...
Breaking Medicine Technology: